Vascular Biology and Metabolism (VAM)

Overview

The Vascular Biology and Metabolism (VAM) area was created to enable a comprehensive, cooperative and multidisciplinary approach to research, development and transference of solutions for a group of diseases that are the leading cause of morbidity and mortality in the world: cardio- and neurovascular diseases, diabetes-metabolic syndrome and kidney failure.

This area also includes a group focused on Ophtalmology research and the Medical Molecular Imaging multidisciplinary group.

Publications

230

total

1,274.219

impact factor

5.542

average impact factor

Director: Rafael Simó

team

zoom

download

Science. The most important milestone has been the demonstration that topical administration of neuroprotective agents is able to arrest the progression of retinal neurodegeneration in type 2 diabetic patients. This is the main result of the EUROCONDOR project (FP7-278040, Coordinator: R. Simó). In addition, 32 peer-review manuscripts have been published, and the most important results have been presented in international meetings.

Projects. We have analysed the results of the EUROCONDOR project. In addition, the following collaborative international projects were developed: e-PREDICE (FP7-279074), MOPEAD (H2020-IMI2-115985), and 3 projects granted by the EFSD (European Foundation for the Study of Diabetes). Moreover, the following national projects were implemented: DTS15/00151, PI15/00823, PI16/00541, SAF2016-77784, and Fundació Marató TV3 (2016-2910). In addition, we started 2 investigator-driven clinical trials (LIRALUNG and CADODIAME).

Innovation. We currently deal with 5 patents (4 already in national phases).

Vascular Biology and Metabolism (VAM)

Overview

Publications

Director: Rafael Simó

Research Areas